TheBusinessResearchCompany published its Non-invasive Prenatal Testing Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global non-invasive prenatal testing market. The report covers the non-invasive prenatal testing market’s segments- consumables, instruments, hospital, diagnostic labs, NGS systems, PCR instruments, microarrays, ultrasound devices, others (centrifuges, UV systems, incubators, microscopes), assay kits &reagents, disposables, trisomy, microdeletion, genetics, Rh factor.
Explore Complete Report https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Non-invasive Prenatal Testing Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp
Next generation sequencing has increased the throughput, scalability, speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next generation sequencing is a platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required, and optimizes the output to generate results regarding genome and DNA testing.
Get Discount On This Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=discount
Chapters from Table of Content:
Chapter 1. Executive Summary
Chapter 2. Non-invasive Prenatal Testing Market Characteristics
Chapter 3. Non-invasive Prenatal Testing Market Size And Growth
Chapter 4. Non-invasive Prenatal Testing Market Segmentation
Chapter 5. Non-invasive Prenatal Testing Market Regional And Country Analysis
…….
Chapter 27. Non-invasive Prenatal Testing Market Trends And Strategies
Chapter 28. Non-invasive Prenatal Testing Market Future Outlook and Potential Analysis
Chapter 29. Appendix
Few Points From List of Tables:
Table 1: Global Historic Market Growth, 2014-2018, $ Billion
Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
Table 3: Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
………..
Table 50: Laboratory Corporation of America Holdings Financial Performance
Table 51: Natera, Inc. Financial Performance
Table 52: PerkinElmer, Inc. Financial Performance
Check our blog for more information at http://blog.tbrc.info/
About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Small DNA fragments in the mother's blood are used to identify particular genetic material (genetic material that defines the makeup of the human cell and protein building blocks).
Every mother's blood contains these tiny particles.Non-invasive prenatal testing (NIPT) exams have produced sufficient data to demonstrate their effectiveness.
The technique has been shown to be both effective and safe for the unborn child, and it has also been shown to help reduce the chances of premature birth and fetal abnormalities.
Certain institutions, however, continue to follow strict rules, as certain research show that NIPT testing might result in false positive findings.
When the mother's blood samples are examined during in vitro fertilization, non-invasive prenatal testing (NIPT) is used to determine the fetus' DNA or genetic make-up using non-invasive techniques.
If they're the same, the infant is considered normal.
The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.
The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
[144 Pages Report] The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.Market DynamicsHigh Risk of Chromosomal Abnormalities With Increasing Maternal AgeGrowing Preference for Noninvasive Techniques Over Invasive MethodsImproving Reimbursement Scenario for NIPTPrograms Focusing on Increasing the Awareness of NIPTThe trisomy applications segment accounted for the largest share of the global NIPT market in 2018.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
This segment is also estimated to grow at the highest CAGR during the forecast period.
The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.
The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size.According to a new market research report “Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) – Global Forecast to 2021″, published by MarketsandMarkets, The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.Browse in-depth TOC on “Non-Invasive Prenatal Testing (NIPT) Market”110 tables48 figures150 pagesDownload PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=145607690The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies).
Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.The Non-Invasive Prenatal Testing Market is segmented based on product, method, application, end user, and region.
Factors such as high risk of chromosomal disorders with increasing maternal age and rising government investments are driving the growth of the NIPT market in this region.
Global Non-Invasive Prenatal Testing (NIPT) Market Research Report: By Product Type (Devices, Consumables, Others), By Techniques (Biochemical Screening Tests, Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, Others) and By End-User (Diagnostic Laboratories, Hospitals, cell DNA screening) – Forecast to 2025Market Highlights:According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition.
As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births.
The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.However, less accuracy of non-invasive prenatal testing compared to invasive prenatal testing is likely to hamper the growth of the global NIPT market during the forecast period.Several market players currently dominate the global NIPT market.
The key players are involved in product launches and strategic collaborations to strengthen their market positions.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8371 Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures.
The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.The non-invasive prenatal testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.
